RPL27 and breast carcinoma: For the study of hypoxia-mediated alterations in gene expression between MCF-7, T-47D, MDA-MB-231 and MDA-MB-468 breast cancer cell lines, GeNorm recommended the combined use of RPL27 and RPLP1.